2014
DOI: 10.1016/j.ymgme.2014.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Nutrition management guideline for maple syrup urine disease: An evidence- and consensus-based approach

Abstract: In an effort to increase harmonization of care and enable outcome studies, the Genetic Metabolic Dietitians International (GMDI) and the Southeast Regional Newborn Screening and Genetics Collaborative (SERC) are partnering to develop nutrition management guidelines for inherited metabolic disorders (IMD) using a model combining both evidence- and consensus-based methodology. The first guideline to be completed is for maple syrup urine disease (MSUD). This report describes the methodology used in its developmen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
151
1
18

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 143 publications
(173 citation statements)
references
References 58 publications
3
151
1
18
Order By: Relevance
“…Treatment for disorders of amino acid metabolism involves avoiding the toxic effects of dietary protein, while at the same time allowing sufficient protein intake for normal growth and development. This process typically uses specialized protein or amino acid restrictive diets (1). These patients require careful monitoring of protein intake for proper growth, which changes with age, development, and other factors (2).…”
mentioning
confidence: 99%
“…Treatment for disorders of amino acid metabolism involves avoiding the toxic effects of dietary protein, while at the same time allowing sufficient protein intake for normal growth and development. This process typically uses specialized protein or amino acid restrictive diets (1). These patients require careful monitoring of protein intake for proper growth, which changes with age, development, and other factors (2).…”
mentioning
confidence: 99%
“…Avoiding an individual’s opinion to be biased by influential factors such as hierarchy and peer pressure. It is of scientific value because it can lead to an agreed set of recommendations to guidelines [8, 15, 16]. …”
Section: Methodsmentioning
confidence: 99%
“…Fortunately for patient carrying some monogenic diseases (estimated to be <5% of the total) (http://www.globalgenes.org), a variety of therapies can alleviate the symptoms of the disease: dietary restrictions or medical food for those affected by Phenylketonuria or Maple syrup urine disease (Frazier et al, ); medicines and medical devices, such as insulin pumps, for those with type I diabetes; implantable defibrillators for the treatment of arrhythmias; organ transplants; and bone marrow transplants for a variety of leukemias. Enzyme replacement therapy, in which the mutant enzyme is replaced with recombinant enzyme, is available for diseases such as Hypophosphatasia (Whyte et al, ) and Gaucher disease, a lysosomal storage disease.…”
Section: Human Inherited Diseases and Their Therapiesmentioning
confidence: 99%